These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24055457)

  • 1. Cancer surveillance for patients with colonic Crohn's disease: will your patients benefit?
    Selinger CP; Leong RW; Andrews JM
    J Crohns Colitis; 2013 Dec; 7(12):e714. PubMed ID: 24055457
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
    J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to Dr. Selinger et al.'s letter.
    Manninen P; Collin P
    J Crohns Colitis; 2013 Dec; 7(12):e715. PubMed ID: 24090906
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.
    Keshteli AH; Baracos VE; Madsen KL
    World J Gastroenterol; 2015 Jan; 21(4):1081-90. PubMed ID: 25632180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer in idiopathic inflammatory bowel disease.
    Harpaz N; Talbot IC
    Semin Diagn Pathol; 1996 Nov; 13(4):339-57. PubMed ID: 8946611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant transformation in inflammatory bowel disease - surveillance guide.
    Stallmach A; Bielecki C; Schmidt C
    Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Colitis-associated colorectal carcinoma: epidemiology, pathogenesis and early diagnosis].
    Scharl M; Biedermann L; Rogler G
    Praxis (Bern 1994); 2014 Jan; 103(3):149-54. PubMed ID: 24468454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.
    Pulusu SSR; Lawrance IC
    Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):711-722. PubMed ID: 28475382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precancerous colorectal lesions (Review).
    Conteduca V; Sansonno D; Russi S; Dammacco F
    Int J Oncol; 2013 Oct; 43(4):973-84. PubMed ID: 23900573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK; Nasioulas G; Kosmidis PA
    Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation in inflammatory bowel disease: prevention, surveillance and treatment - new techniques in endoscopy.
    Bojarski C
    Dig Dis; 2009; 27(4):571-5. PubMed ID: 19897977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colorectal cancer in inflammatory bowel disease.
    Subramanian V; Logan RF
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression stability of common housekeeping genes is differently affected by bowel inflammation and cancer: implications for finding suitable normalizers for inflammatory bowel disease studies.
    Krzystek-Korpacka M; Diakowska D; Bania J; Gamian A
    Inflamm Bowel Dis; 2014 Jul; 20(7):1147-56. PubMed ID: 24859296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural history of intestinal lesions in inflammatory bowel disease].
    Beaugerie L
    Rev Prat; 2014 Nov; 64(9):1226-9. PubMed ID: 25638859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of dysplasia and cancer in inflammatory bowel disease.
    Mescoli C; Frego M; Rugge M
    Ann Ital Chir; 2011; 82(1):11-8. PubMed ID: 21657150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk of cancer in chronic inflammatory bowel diseases].
    Fischbach W
    Leber Magen Darm; 1992 May; 22(3):96-101. PubMed ID: 1625513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
    Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.